Taysha Gene Therapies Inc (TSHA)
Stock-Based Compensation
$18.17M
TTM · Period ending: · USD
TSHA Stock-Based Compensation
Latest reported$18.17Mperiod ending
Latest reported$18.17Mperiod ending
TSHA TTM Stock-Based Comp ($1.34M → $18.17M)
TTM stock-based compensation
High-resolution chart · PNG
TSHA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 18,171,000 | |
| 15,551,000 | |
| 13,298,000 | |
| 12,985,000 | |
| 13,057,000 | |
| 13,199,000 | |
| 13,103,000 | |
| 11,855,000 | |
| 10,538,000 | |
| 9,428,000 | |
| 7,905,000 | |
| 10,040,000 | |
| 12,470,000 | |
| 14,389,000 | |
| 18,043,000 | |
| 18,895,000 | |
| 19,511,000 | |
| 19,919,000 | |
| 18,184,000 | |
| 15,242,000 | |
| 11,497,000 | |
| 6,948,000 | |
| 3,354,000 | |
| 1,341,000 |